InvestorsHub Logo
Followers 11
Posts 834
Boards Moderated 0
Alias Born 02/19/2014

Re: Evaluate post# 11657

Wednesday, 05/28/2014 7:56:08 PM

Wednesday, May 28, 2014 7:56:08 PM

Post# of 704651
I was fully aware of the fine print in the pr identifying that only questions pertaining to direct would be responded to in the cc. I am of the opinion that there have been aspects of the L trial that could be discussed yet are not. I very much appreciate the update pertaining to direct, and will continue to hold for what I believe to be ground breaking therapy, yet the constant back and forth is starting to wear me down in all honesty. I am waiting for the day that NWBO can smother all the naysayers with data, PR's, guidance and vision. To the relief of cancer patients worldwide. I hope I am right, yet the jury is still out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News